Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Kansas City, Missouri
Resectable Pancreatic Ductal Adenocarcinoma (PDAC) Clinical Trials in Kansas City, Missouri
1 recruiting
Kansas City, Missouri
Showing
1–1
of
1
trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Cancer
PDAC
PDAC - Pancreatic Ductal Adenocarcinoma
+2 more
Revolution Medicines, Inc.
500 enrolled
17 locations
NCT07252232
Feedback